The Important Role of Lipoprotein(a) in Cardiovascular Disease: Present & Future Therapeutic Options

Date: Sunday, Nov. 12
Time: 6:30-9:30 p.m.
Sponsored by: AcademicCME
Supported by: Amgen, Inc; Akcea Therapeutics and Kaneka Pharma America LLC
Location: Hilton Anaheim, California Ballroom D
Address: 777 W. Convention Way

Please join Dr. Patrick Moriarty, Dr. Sergio Fazio, Dr. Marlys Koschinsky, Dr. Borge Nordestgaard and Dr. George Thanassoulis on Sunday, Nov. 12, at the Hilton Anaheim in Ballroom D for a live symposium focusing on the role of the role of lipoprotein(a) and its therapeutic options for patients with cardiovascular disease. A buffet dinner will begin at 6:30 p.m. and the educational activity will begin at 7 p.m. A review of the science of Lp(a) and its role in the management and prevention of cardiovascular risk will be discussed. The expert faculty will examine clinical trial data and mechanisms of action of emerging therapeutics to reduce Lp(a). Information regarding how to apply emerging science into individualized treatment strategies to optimally manage Lp(a) and improve cardiovascular outcomes will be reviewed. The educational material of this symposium will provide crucial information for cardiologist to improve outcomes in patients with cardiovascular disease. Register now at

This content is provided as information only and does not reflect the opinions of the AHA, nor does AHA review or approve the programming. These events are not part of the official AHA Scientific Sessions 2017 as planned by the AHA Committee on Scientific Sessions Programming. These events are part of the unofficial symposia offered concurrently with Scientific Sessions.